Abbott Receives FDA Clearance for Two New Over-the-Counter Glucose Monitors

Jun 10, 2024, 12:30 PM

Abbott has received clearance from the U.S. Food and Drug Administration (FDA) for two new over-the-counter continuous glucose monitoring (CGM) systems. This approval allows these CGM systems to be sold without a prescription, making them more accessible to consumers. The announcement was made on Monday by Abbott, and it marks a significant step in the availability of diabetes management tools.